2022 Annual Meeting | C145 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Date Wednesday 04/06/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Meredith Wicklund, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms. Participants will additionally become familiar with the first ever disease modifying treatment for dementia and its role in clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT	Introduction	Introduction/Opening Remarks Meredith Wicklund, MD, FAAN
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Meredith Wicklund, MD, FAAN
03:35 PM - 04:10 PM PDT	Speaker	Pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia Lealani M. Acosta, MD, MPH, FAAN
04:10 PM - 04:45 PM PDT	Speaker	Non-pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia Julio C. Rojas-Martinez, MD, PhD
04:45 PM - 05:20 PM PDT	Speaker	Disease-modifying Treatment in Dementia Meredith Wicklund, MD, FAAN
05:20 PM - 05:30 PM PDT	Q&A	Questions and Answers Meredith Wicklund, MD, FAAN

Faculty Disclosures
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Julio C. Rojas-Martinez, MD, PhD	Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.

��ɫ��

��ɫ��